[
  {
    "ts": "2025-12-03T06:57:38+00:00",
    "headline": "Johnson & Johnson’s (JNJ) Multiple Myeloma Breakthrough Drives Buy Rating From Guggenheim",
    "summary": "Johnson & Johnson (NYSE:JNJ) ranks among the Best Low Volatility Investments in December 2025. On November 25, Guggenheim reaffirmed a Buy rating and $206 price target on healthcare giant Johnson & Johnson (NYSE:JNJ), citing favorable clinical trial findings for its multiple myeloma therapy. The firm noted preliminary data from the MajesTEC-3 trial, which combines Johnson […]",
    "url": "https://finance.yahoo.com/news/johnson-johnson-jnj-multiple-myeloma-065738531.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "761ea6ba-5dc1-38e3-9672-461494167165",
      "content": {
        "id": "761ea6ba-5dc1-38e3-9672-461494167165",
        "contentType": "STORY",
        "title": "Johnson & Johnson’s (JNJ) Multiple Myeloma Breakthrough Drives Buy Rating From Guggenheim",
        "description": "",
        "summary": "Johnson & Johnson (NYSE:JNJ) ranks among the Best Low Volatility Investments in December 2025. On November 25, Guggenheim reaffirmed a Buy rating and $206 price target on healthcare giant Johnson & Johnson (NYSE:JNJ), citing favorable clinical trial findings for its multiple myeloma therapy. The firm noted preliminary data from the MajesTEC-3 trial, which combines Johnson […]",
        "pubDate": "2025-12-03T06:57:38Z",
        "displayTime": "2025-12-03T06:57:38Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/000ff4c9b12edba78f9454e5e1cb462e",
          "originalWidth": 700,
          "originalHeight": 525,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/juOPps7.DAlqGqaqLgELRQ--~B/aD01MjU7dz03MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/000ff4c9b12edba78f9454e5e1cb462e.cf.webp",
              "width": 700,
              "height": 525,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Zw.inBgmtGjrav77270FFg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/000ff4c9b12edba78f9454e5e1cb462e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-jnj-multiple-myeloma-065738531.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-jnj-multiple-myeloma-065738531.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-03T13:00:00+00:00",
    "headline": "Johnson & Johnson Teams Up with Naomi Watts to Reveal Why an Eye Exam is the Ultimate Self-Care Move for Women Over 40",
    "summary": "Johnson & Johnson (NYSE: JNJ) – Johnson & Johnson, a global leader in eye health, has partnered with Academy Award–nominated actress, producer, and entrepreneur, Naomi Watts, to change the conversation about vision. Together, they'll encourage simple, practical steps—such as routine eye checks and reframing eye care as part of holistic healthy aging, so that it becomes an easy and empowering part of daily self-care.",
    "url": "https://finance.yahoo.com/news/johnson-johnson-teams-naomi-watts-130000280.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "71da50a3-8416-3542-b5e8-9af6512d7ad2",
      "content": {
        "id": "71da50a3-8416-3542-b5e8-9af6512d7ad2",
        "contentType": "STORY",
        "title": "Johnson & Johnson Teams Up with Naomi Watts to Reveal Why an Eye Exam is the Ultimate Self-Care Move for Women Over 40",
        "description": "",
        "summary": "Johnson & Johnson (NYSE: JNJ) – Johnson & Johnson, a global leader in eye health, has partnered with Academy Award–nominated actress, producer, and entrepreneur, Naomi Watts, to change the conversation about vision. Together, they'll encourage simple, practical steps—such as routine eye checks and reframing eye care as part of holistic healthy aging, so that it becomes an easy and empowering part of daily self-care.",
        "pubDate": "2025-12-03T13:00:00Z",
        "displayTime": "2025-12-03T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/9b8b4196fa0e25ca1c4d50674e71777b",
          "originalWidth": 400,
          "originalHeight": 114,
          "caption": "(PRNewsfoto/Johnson & Johnson MedTech)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/62W8eGrAL3UBga9KAmqt_g--~B/aD0xMTQ7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/9b8b4196fa0e25ca1c4d50674e71777b.cf.webp",
              "width": 400,
              "height": 114,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xxITbzQL4G3m4cNU9W4JmA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/9b8b4196fa0e25ca1c4d50674e71777b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-teams-naomi-watts-130000280.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-teams-naomi-watts-130000280.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-03T14:00:05+00:00",
    "headline": "Is Most-Watched Stock Johnson & Johnson (JNJ) Worth Betting on Now?",
    "summary": "Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
    "url": "https://finance.yahoo.com/news/most-watched-stock-johnson-johnson-140005928.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "8d5b4465-a753-3e31-8a44-c3e1f489208a",
      "content": {
        "id": "8d5b4465-a753-3e31-8a44-c3e1f489208a",
        "contentType": "STORY",
        "title": "Is Most-Watched Stock Johnson & Johnson (JNJ) Worth Betting on Now?",
        "description": "",
        "summary": "Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
        "pubDate": "2025-12-03T14:00:05Z",
        "displayTime": "2025-12-03T14:00:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/3496571a811465d910e99bd171c71a94",
          "originalWidth": 900,
          "originalHeight": 588,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5gRNxwBpnI6i3Dv1dI7wfg--~B/aD01ODg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3496571a811465d910e99bd171c71a94.cf.webp",
              "width": 900,
              "height": 588,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3D4iv84vYyo09.dnUK_wsg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3496571a811465d910e99bd171c71a94.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/most-watched-stock-johnson-johnson-140005928.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/most-watched-stock-johnson-johnson-140005928.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]